Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haluska

Showing results (281-290 of 366) with videos related to

Pageof 37
Sort By:
Microsystems & Nanoengineering|February 25, 2022
High-speed identification of suspended carbon nanotubes using Raman spectroscopy and deep learningJian Zhang, Mickael L Perrin, Luis Barba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other BiomarkersSuzanne George, Margaret von Mehren, Jonathan A Fletcher, et al.
Gynecologic Oncology|April 26, 2011
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinomaS John Weroha, Ann L Oberg, Katie L Allen Ziegler, et al.
Oncotarget|October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumorsAndrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948B V Clineschmidt, D J Pettibone, D R Reiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2014
Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumorsPaul Haluska, Michael Menefee, Elizabeth R Plimack, et al.
European Heart Journal. Cardiovascular Imaging|May 22, 2015
Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†Thomas H Marwick, Thierry C Gillebert, Gerard Aurigemma, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 5, 2015
Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)Thomas H Marwick, Thierry C Gillebert, Gerard Aurigemma, et al.
Breast Cancer Research and Treatment|April 23, 2013
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancerCynthia X Ma, Vera J Suman, Matthew Goetz, et al.
Gynecologic Oncology|May 3, 2017
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancersGerardo Colon-Otero, S John Weroha, Nathan R Foster, et al.
Pageof 37

Showing results (281-290 of 366) with videos related to

Sort By:
Pageof 37
Microsystems & Nanoengineering|February 25, 2022
High-speed identification of suspended carbon nanotubes using Raman spectroscopy and deep learningJian Zhang, Mickael L Perrin, Luis Barba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other BiomarkersSuzanne George, Margaret von Mehren, Jonathan A Fletcher, et al.
Gynecologic Oncology|April 26, 2011
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinomaS John Weroha, Ann L Oberg, Katie L Allen Ziegler, et al.
Oncotarget|October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumorsAndrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948B V Clineschmidt, D J Pettibone, D R Reiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2014
Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumorsPaul Haluska, Michael Menefee, Elizabeth R Plimack, et al.
European Heart Journal. Cardiovascular Imaging|May 22, 2015
Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†Thomas H Marwick, Thierry C Gillebert, Gerard Aurigemma, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 5, 2015
Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)Thomas H Marwick, Thierry C Gillebert, Gerard Aurigemma, et al.
Breast Cancer Research and Treatment|April 23, 2013
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancerCynthia X Ma, Vera J Suman, Matthew Goetz, et al.
Gynecologic Oncology|May 3, 2017
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancersGerardo Colon-Otero, S John Weroha, Nathan R Foster, et al.
Pageof 37